OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis
Xiaoyong Xue, Jianzhi Wu, Mingning Ding, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Si-Wu-Tang attenuates hepatocyte PANoptosis and M1 polarization of macrophages in non-alcoholic fatty liver disease by influencing the intercellular transfer of mtDNA
Zhi Ma, Kaihong Xie, Xiaoyong Xue, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118057-118057
Closed Access | Times Cited: 9

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Yulin Zhang, Zhen-Jiao Li, Hong-Zhong Gou, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 37

Si-Wu-Tang attenuates liver fibrosis via regulating lncRNA H19-dependent pathways involving cytoskeleton remodeling and ECM deposition
Jiaorong Qu, Xiaoyong Xue, Zhixing WANG, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 1, pp. 31-46
Closed Access | Times Cited: 8

Ultrasensitive electrochemical detection of bile acids via ZIF-67-MOF-derived CoNi(OH)x/CeO2/COOH-MWCNTs composite electrodes
Lei Liu, Chuanqin Zhou, Yanping Wei, et al.
Microchemical Journal (2024) Vol. 201, pp. 110662-110662
Closed Access | Times Cited: 5

Therapeutic potential and mechanism of Chinese herbal medicines in treating fibrotic liver disease
Yanwei Li, Yunrui LU, Mozuo NIAN, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 9, pp. 643-657
Closed Access | Times Cited: 11

Dynamics of the gut-liver axis in rats with varying fibrosis severity
Hongyan Xiang, Zongyi Liu, Huanyu Xiang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 8, pp. 3390-3404
Open Access | Times Cited: 17

Therapeutic Mechanism of Cornus Officinalis Fruit Coreon on ALI by AKT/Nrf2 Pathway and Gut Microbiota
Ting Zhang, Huili Kang, Qin Peng, et al.
Phytomedicine (2024) Vol. 130, pp. 155736-155736
Closed Access | Times Cited: 3

Si-Wu-Tang ameliorates bile duct ligation-induced liver fibrosis via modulating immune environment
Zhi Ma, Xiaoyong Xue, Jinzhao Bai, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113834-113834
Open Access | Times Cited: 13

Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota
Junbin Yan, Yunmeng Nie, Yuan Liu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 12

Predictive value of serum bile acids as metabolite biomarkers for liver cirrhosis: a systematic review and meta-analysis
Xu Han, Juan Wang, Hao Gu, et al.
Metabolomics (2022) Vol. 18, Iss. 7
Closed Access | Times Cited: 10

Traditional Chinese medicine targets on hepatic stellate cells for the treatment of hepatic fibrosis: A mechanistic review
Dengcheng Hui, Lu Liu, Yanqin Bian, et al.
Portal hypertension & cirrhosis (2023) Vol. 2, Iss. 1, pp. 16-31
Open Access | Times Cited: 6

Sodium alginate combined with oxymatrine ameliorates CCl4-induced chemical hepatic fibrosis in mice
Chen He, Wenjing Wang, Guoli Wei, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111144-111144
Closed Access | Times Cited: 6

Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
Dongmei Wang, J. Y. Liu, Ling Zhong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10

Intestinal microbiota in biliary diseases
Qiyun Xia, Qiaoyan Liu, Xiong Ma
Current Opinion in Gastroenterology (2023) Vol. 39, Iss. 2, pp. 95-102
Closed Access | Times Cited: 4

Niujiao Dihuang Jiedu decoction promotes SLC7A11 m5C methylation modification against ferroptosis in acute-on-chronic liver failure
Liqiao Huang, Jie Liu, Yubo Jin, et al.
Phytomedicine (2023) Vol. 122, pp. 155136-155136
Closed Access | Times Cited: 4

Roles of gut microbiome-associated metabolites in pulmonary fibrosis by integrated analysis
Jie Li, Wenqing Wu, Xinyi Kong, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1

Hepatoprotective Efficacy and Interventional Mechanism of Qijia Rougan Decoction in Liver Fibrosis
Xiaofeng Chen, Yumei Wang, Shaoxiu Ji, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6

The gut microbiota: A new perspective for tertiary prevention of hepatobiliary and gallbladder diseases
Xiaoyu Huang, Yi Yang, Xueli Li, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 3

Page 1

Scroll to top